Pricing Log in Create free account

Atossa Therapeutics, Inc. (ATOS) vs Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX)

Atossa Therapeutics, Inc. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are both Biotechnology companies. Atossa Therapeutics, Inc. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are of similar size ($20.2M and $18.5M). Across the 9 metrics below, Atossa Therapeutics, Inc. leads on 6 and Quoin Pharmaceuticals, Ltd. Sponsored ADR on 3.

Valuation

Metric ATOS QNRX Biotechnology median
P/E n/m n/m 10.60
P/S 479.89 n/m 9.40
P/B 0.72 2.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 n/m 0.66
EV/Sales (173.58) n/m 9.02
Earnings yield (202.89%) (331.86%) (32.88%)
Free cash flow yield (186.04%) (27.69%) (23.13%)

Profitability

Metric ATOS QNRX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (89.23%) (575.73%) (51.96%)
Return on assets (77.91%) (178.77%) (46.06%)
Return on invested capital (3,918.83%) 0.00% 0.00%

Growth

Metric ATOS QNRX Biotechnology median
Revenue growth (TTM) (93.66%) — 6.76%
EPS growth (last fiscal year) (34.73%) 77.84% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATOS QNRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.69 1.76 4.97
Net debt to EBITDA 1.12 1.16 1.01

Dividend

Metric ATOS QNRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATOS QNRX Biotechnology median
Market cap 20.16m 18.48m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack